Records containing: Osteoporosis, Postmenopausal
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-01-28Randomized Double-Blind Placebo-Controlled and Parallel Group Study to Evaluate the Impact of One Year Therapy With Monthly Oral Ibandronate 150 mg on Structural Properties of Bone in Postmenopausal Osteoporosis Without Vertebral Fractures
-
CLINICAL_TRIALS study record update · 2008-05-09Influence of Alfacalcidol on Falls in Elderly Postmenopausal, Alendronate-Treated, Osteopenic/Osteoporotic Women With High Risk of Falls
-
CLINICAL_TRIALS study record update · 2008-05-01Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
-
CLINICAL_TRIALS study record update · 2008-05-01Effects of LY333334 in the Treatment of Postmenopausal Women With Osteoporosis
-
CLINICAL_TRIALS study record update · 2008-03-11Multicenter and Prospective Study to Determine the Satisfaction With Actonel (Risedronate Sodium) 35mg Once a Week Using Biochemical Markers of Bone as a Control, in Postmenopausal Women With Osteoporosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-03-11A Multicenter, Prospective, Randomized, 2-Way Crossover, Open-Label Study pn Postmenopausal Women With Osteoporosis Examining Subject Satisfaction and Compliance When Risedronate Sodium (Actonel) in Administered 35mg Once a Week or 5mg Once Daily
-
CLINICAL_TRIALS study record update · 2007-10-30A Multicenter, Prospective, Randomized, 2-Way Crossover, Open-Label Phase IV Study in Postmenopausal Women With Osteoporosis Examining Subject Satisfaction and Compliance When Actonel(Rosedronate) is Administered 35mg Once a Week or 5mg
-
CLINICAL_TRIALS study record update · 2007-10-12Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis
-
CLINICAL_TRIALS study record update · 2007-07-16Comparison of a 2-Year Therapy of Teriparatide Alone and Its Sequential Use for 1 Year, With or Without Raloxifene HCl, in the Treatment of Severe Postmenopausal Osteoporosis
-
CLINICAL_TRIALS study record update · 2007-05-15Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
-
CLINICAL_TRIALS study record update · 2006-08-18Effects of Black Cohosh on Menopausal Hot Flashes
-
CLINICAL_TRIALS study record update · 2006-07-20ClinicalTrials.gov study NCT00046137